Hantz Financial Services Inc. Raises Stock Holdings in Roche Holding AG $RHHBY

Hantz Financial Services Inc. increased its position in Roche Holding AG (OTCMKTS:RHHBY) by 164.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 79,732 shares of the company’s stock after buying an additional 49,633 shares during the quarter. Hantz Financial Services Inc.’s holdings in Roche were worth $4,112,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in RHHBY. Curio Wealth LLC purchased a new position in shares of Roche in the third quarter worth $25,000. Oakworth Capital Inc. purchased a new position in shares of Roche in the third quarter worth $57,000. Douglass Winthrop Advisors LLC purchased a new position in shares of Roche in the third quarter worth $201,000. Albert D Mason Inc. purchased a new position in shares of Roche in the fourth quarter worth $207,000. Finally, Enterprise Financial Services Corp purchased a new position in shares of Roche in the fourth quarter worth $270,000.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. Argus upgraded shares of Roche from a “hold” rating to a “buy” rating in a report on Monday, April 6th. Citigroup assumed coverage on shares of Roche in a report on Tuesday, January 27th. They issued a “buy” rating on the stock. TD Cowen reiterated a “hold” rating on shares of Roche in a report on Tuesday, February 10th. Morgan Stanley upgraded shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 price target on the stock in a report on Friday, April 24th. Finally, Wolfe Research reiterated an “outperform” rating on shares of Roche in a report on Thursday, February 26th. Five research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $51.50.

Roche Stock Performance

OTCMKTS:RHHBY opened at $53.34 on Tuesday. The firm’s fifty day simple moving average is $50.52 and its 200 day simple moving average is $51.89. Roche Holding AG has a twelve month low of $37.51 and a twelve month high of $60.85. The company has a current ratio of 1.38, a quick ratio of 1.12 and a debt-to-equity ratio of 0.72.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.